Hansoh Pharmaceutical Group Co Ltd - Net Income Including Non Controlling Interests
Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Net-Income-Including-Non-Controlling-Interests" stands at 4.68 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 03/31/2017, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.93 percent compared to the value the year prior.
The 1 year change in percent is 8.93.
The 3 year change in percent is 72.14.
The 5 year change in percent is 108.30.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 06/30/2025, is +210.96%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.
Net Income Including Non Controlling Interests for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Net Income Including Non Controlling Interests | 905,699,262,464.00 |
 | Johnson & Johnson - Net Income Including Non Controlling Interests | 486,508,953,600.00 |
 | AbbVie Inc - Net Income Including Non Controlling Interests | 399,570,305,024.00 |
 | Roche Holding AG - Net Income Including Non Controlling Interests | 317,433,206,677.55 |
 | AstraZeneca PLC - Net Income Including Non Controlling Interests | 280,205,508,085.11 |